Chemokines and regulation of T cell responses during infection
Chemokines and regulation of T cell responses during infection
批准号:
7839589
负责人:
Abhay R Satoskar
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-14 至 2011-07-31
关键词:
AcuteAgonistAnti-Inflammatory AgentsAnti-inflammatoryAntigen-Presenting CellsAntigensAssesAutoimmune ProcessC57BL/6 MouseCD8B1 geneCXC chemokine receptor 3CXCL10 geneCXCL9 geneCXCR3 geneCellsChronicCutaneousDataDefectDendritic CellsDermisDiseaseEffector CellGoalsHealedHost DefenseHost resistanceImmuneImmunityImmunotherapeutic agentInbred BALB C MiceInfectionInfection ControlInflammationInflammatoryInterferonsInterleukin-4LeadLeishmaniaLeishmaniasisLesionLigandsMediatingMemoryMusNatural Killer CellsParasite ControlParasitesPathway interactionsPhasePlayPredispositionProductionRecruitment ActivityRegulationResearchResistanceResolutionRheumatoid ArthritisRoleSiteSkinT cell regulationT memory cellT-Cell ReceptorT-LymphocyteTestingTransgenic Organismscell motilitychemokinecytokinedesignhealingimmune functionin vivoinsightlymph nodesmacrophagemicrobialmigrationneutrophilpathogenpreventreceptorresponsetherapeutic vaccinetrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Chemokines regulate the traffick and function of various immune effector cells and play a critical role in host
defense against a variety of intracellular pathogens. The CXC chemokine receptor 3 (CXCR3) is expressed on
plasmacytoid dendritic cells, neutrophils, natural killer (NK) cells, and T cells. CXCR3 ligands (CXCR3Ls),
particularly CXCL9 (Mig) and CXCL10 (IP-10) are produced in high levels during Leishmania infection but their
role in mediating protective immunity against leishmaniasis is poorly defined. We have shown previously that
CXCR3 plays a key role in mediating immunity against cutaneous L. major infection in resistant C57BL/6 mice
by controlling recruitment of CD4+ and CD8+ T cells to the infected skin and IFN-? production within the lesion.
We have also found that CXCR3 is expressed on a significant proportion of memory T cells and is required for
their migration to the dermis after re-challenge. Our preliminary studies show that T cells from L. majorsusceptible
BALB/c mice, but not resistant C57BL/6 mice, fail to up-regulate CXCR3 upon activation despite
producing comparable levels of IFN-? as C57BL/6 T cells. Our recent study shows that distinct cytokinedependent
mechanisms control the expression of CXCR3 on CD4+ and CD8+ T cells. We have also found that
the B7 co-stimulatory pathway is involved in maintaining and regulating CXCR3 expression on T cells in L.
major-resistant mice. These findings lead us to hypothesize that CXCR3 regulates host resistance against L.
major by controlling parasite-specific effector and memory T cell responses and that BALB/c mice have a
defect in up-regulating CXCR3 on T cells which contributes to their susceptibility to L. major. The goals of this
proposal are to asses the role of CXCR3 in regulation of Leishmania-specific effector and memory T cell
responses during L. major infection and to determine how CXCR3 expression is controlled on T cells. (Aim 1)
will examine the role of CXCR3 in regulation of antigen-specific effector CD4+ and CD8+ T cell responses
during primary L. major infection in resistant C57BL/6 mice. (Aim2) will determine the role of CXCR3 in the
regulation of memory T cell recruitment and function during L. major infection in C57BL/6 mice. (Aim 3) will
determine the mechanisms by which the expression of CXCR3 is up-regulated on CD4+ and CD8+ T cells in
C57BL/6 mice and will elucidate the cytokine pathways that are involved in preventing the induction of CXCR3
on T cells in susceptible BALB/c mice. In addition, we will determine whether CXCR3 levels can be
manipulated in vivo by targeting these pathways in efforts to ameliorate infection in BALB/c mice. Finally, we
will also study the role of B7:CD28 co-stimulatory pathway in CXCR3 regulation on T cells using specific
pathway agonists and antagonists. These complementary approaches should provide insights into the role of
CXCR3 in the regulation of antigen-specific effector and memory T cell responses during infection. These
studies are important because they will not only enable us to optimize therapeutic and vaccine strategies
against microbial infections by targeting chemokines and their receptors, but will eventually aid in designing
immunotherapeutic approaches to treat autoimmune inflammatory diseases such as rheumatoid arthritis
through blocking the recruitment of pathogenic T cells into the site of inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a live attenuated vaccine for visceral leishmaniasis
-
批准号:9725441
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2020
-
负责人:Abhay R Satoskar
-
依托单位:
Development of a live attenuated vaccine for visceral leishmaniasis
-
批准号:10115582
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2020
-
负责人:Abhay R Satoskar
-
依托单位:
A live attenuated vaccine for leishmaniasis
-
批准号:9753154
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2018
-
负责人:Abhay R Satoskar
-
依托单位:
Treating cutaneous leishmaniasis by radio-frequency induced heat (RFH) therapy
-
批准号:8331827
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2012
-
负责人:Abhay R Satoskar
-
依托单位:
Chemopreventition and treatment of non-melanoma skin cancer by targeting MIF
-
批准号:8230915
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2012
-
负责人:Abhay R Satoskar
-
依托单位:
Chemopreventition and treatment of non-melanoma skin cancer by targeting MIF
-
批准号:8434824
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2012
-
负责人:Abhay R Satoskar
-
依托单位:
Visualization of CXCR3 allelic usage in vivo
-
批准号:7957584
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2010
-
负责人:Abhay R Satoskar
-
依托单位:
Visualization of CXCR3 allelic usage in vivo
-
批准号:8066661
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2010
-
负责人:Abhay R Satoskar
-
依托单位:
Discovery of novel antileishmanial molecules from the plant Pentalinon andreuxii
-
批准号:8083173
-
项目类别:
-
资助金额:$80.4万
-
财政年份:2010
-
负责人:Abhay R Satoskar
-
依托单位:
Treatment of cutaneous leishmaniasis using Pentalinon andrieuxii root extract
-
批准号:7584697
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2009
-
负责人:Abhay R Satoskar
-
依托单位:
Treatment of cutaneous leishmaniasis using Pentalinon andrieuxii root extract
-
批准号:7762723
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2009
-
负责人:Abhay R Satoskar
-
依托单位:
Chemokines and regulation of T cell responses during infection
-
批准号:7681864
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2008
-
负责人:Abhay R Satoskar
-
依托单位:
Isolation of novel antileishmanial molecules from Pentalinon andrieuxii root
-
批准号:7532435
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2008
-
负责人:Abhay R Satoskar
-
依托单位:
Isolation of novel antileishmanial molecules from Pentalinon andrieuxii root
-
批准号:7688525
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2008
-
负责人:Abhay R Satoskar
-
依托单位:
Mechanisms of sex-determined resistance to L. mexicana
-
批准号:6747542
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2002
-
负责人:Abhay R Satoskar
-
依托单位:
Mechanisms of sex-determined resistance to L. mexicana
-
批准号:6626160
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2002
-
负责人:Abhay R Satoskar
-
依托单位:
Mechanisms of sex-determined resistance to L. mexicana
-
批准号:6896104
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2002
-
负责人:Abhay R Satoskar
-
依托单位:
Mechanisms of sex-determined resistance to L. mexicana
-
批准号:6487084
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2002
-
负责人:Abhay R Satoskar
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: